Abstract | BACKGROUND: Neuroendocrine cervical carcinoma (NECC) is a rare and aggressive subtype of cervical cancer. To date, no NECC cell-based model is available, which hinders the development of new therapeutic strategies for NECC. In this study, we derived a new NECC cell line from an ex vivo biopsy and used it to explore novel drug combination approach for NECC. RESULTS: The stable HM-1 cell line displayed high expression levels of the neuroendocrine marker, synaptophysin. HM-1 cell transplantation could induce tumor growth in nude mice. As expected, the combination of etoposide and cisplatin synergistically inhibited HM-1 cell proliferation. Strikingly, when etoposide and cisplatin were combined with PI3K inhibitor BEZ235, the growth of HM-1 cells was significantly reduced. Taken together, the data implied the combination of etoposide and cisplatin with BEZ235 not only inhibited HM-1 cell proliferation but also increased cell apoptosis. MATERIALS AND METHODS: A NECC tissue sample from a 75-year-old female patient was processed to derive a primary cell line annotated as HM-1. The features of HM-1 were analyzed to establish its characteristic profile. Next, HM-1 was treated with PI3K inhibitors, BKM120 and/or BEZ235, in combination with two well-known genotoxic drugs, etoposide and/or cisplatin, to evaluate which combination could serve as a more effective treatment approach. Their inhibiting effects on HM-1 were evaluated by cell viability, apoptosis, and target kinase expression. CONCLUSIONS: The newly established NECC cell line HM-1 could serve as a cell-based model for NECC research. The synergistic drug combination of PI3K inhibitor with genotoxic drugs might become a potential new treatment strategy against NECC.
|
Authors | Zih-Yin Lai, Hsin-Yueh Yeo, Ya-Tse Chen, Kuo-Ming Chang, Tze-Chien Chen, Yung-Jen Chuang, Shing-Jyh Chang |
Journal | Oncotarget
(Oncotarget)
Vol. 8
Issue 28
Pg. 45323-45334
(Jul 11 2017)
ISSN: 1949-2553 [Electronic] United States |
PMID | 28484083
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Biomarkers
- Phosphoinositide-3 Kinase Inhibitors
- Etoposide
- Cisplatin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Biomarkers
- Carcinoma, Neuroendocrine
(drug therapy, etiology, metabolism, pathology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Cisplatin
(pharmacology)
- DNA Damage
(drug effects)
- Disease Models, Animal
- Drug Synergism
- Etoposide
(pharmacology)
- Female
- Humans
- Mice
- Papillomavirus Infections
(complications, virology)
- Phosphoinositide-3 Kinase Inhibitors
- Uterine Cervical Neoplasms
(drug therapy, etiology, metabolism, pathology)
- Xenograft Model Antitumor Assays
|